인쇄하기
취소

More R&D investment and globalization is daunting challenge for Korea

Published: 2010-08-10 06:59:00
Updated: 2010-08-10 06:59:00
The Korean government’s new drug pricing policy and crackdown on rebates is ultimately designed to encourage domestic drug manufacturers to invest in R&D for the development of new drugs.

According to government data, 14,900 medical entities were registered for health insurance coverage as of December 2008. Of them, generics account for 79.1 percent. A generic drug refers to a drug which con...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.